Asia Pacific blood pressure monitoring devices market is set for strong growth, rising from USD 1.05 billion in 2025 to USD 3.04 billion by 2035, at a CAGR of 11.20%, driven by rising hypertension cases, digital health adoption, and expanding homecare monitoring solutions.

Asia Pacific Blood Pressure Monitoring Devices Market Statical Scope

The Asian Pacific industry is experiencing a surge in technological advancements like wearable and smart devices, and telehealth due to the rising risk of hypertension among young people and elderly groups.

The Asia Pacific countries, like India, are witnessing a strong support of the Ayushman Bharat, including Ayushman Arogya Mandir and Pradhan Mantri Ayushman Bharat Health Infrastructure Mission (PM-ABHIM). According to the Ministry of Health and Family Welfare, India achieved a great success in establishing 1,50,000 health and wellness centers, aiming to provide comprehensive primary care. The Asia Pacific region represents a smart medical devices sector in countries like India, comprising simple diagnostic tools to complex Artificial Intelligence -based imaging systems and implantable devices such as advanced imaging machines, stents, and digital health solutions.

Asia Pacific Blood Pressure Monitoring Devices Market Share, By Device Type, 2025 (%)

• Non-Smart/Traditional Type- The non-smart/traditional type segment led the market in 2025, with a revenue share of 60%, owing to the promising nature of conventional medical devices in delivering immediate patient care through affordable treatments.
• Smart Type- The smart type segment is expected to be the fastest-growing in the market during the forecast period, with a share of 40%, driven by the novel innovations by medical device companies while introducing smart healthcare equipment.

Asia Pacific Blood Pressure Monitoring Devices Market Share, By Connectivity, 2025 (%)

• Non-Connected- The non-connected segment occupied a dominating position in the market in 2025 by holding a major revenue share of 75%, owing to the traditional treatment approaches requiring manual interventions in clinics and other patient care settings.
• Connected- The connected segment is anticipated to grow at a rapid rate in the market during the studied period, and holds a share of 25%. This segmental growth is attributed to the acceptance of digital tools and technologies in the routine workflows of the medical sector.

Asia Pacific Blood Pressure Monitoring Devices Market Share, By End Use, 2025 (%)

• Hospitals- The hospitals segment accounted for a supremacy position in the market in 2025, with a remarkable share of 50%, because of the global expansion of healthcare systems, including affordable and accessible treatment plans offered by hospitals.
• Ambulatory Surgery Centers and Clinics- The ambulatory surgery centers and clinics segment is expected to expand significantly in the market, with a substantial share of 30%, due to the growing number of surgeries related to oncology, cardiology, neurology, diabetes, nervous system disorders, offered by well-equipped surgery centers.
• Homecare- The homecare segment is projected to occupy a booming position in the market in the upcoming period, with a considerable share of 20%, driven by the growing elderly population, dealing with severe health disorders, and requiring personalized home healthcare.

Top Companies in the Asia Pacific Blood Pressure Monitoring Devices Market

• Omron Healthcare
• Welch Allyn, Inc.
• A&D Medical Inc.
• SunTech Medical, Inc.
• American Diagnostics Corporation
• Withings
• Briggs Healthcare
• GE Healthcare
• Kaz Inc.
• Microlife AG
• Rossmax International Ltd.
• GF Health Products Inc.
• Spacelabs Healthcare Inc.
• Philips Healthcare.
• B. Braun SE

Segments Covered in the Report

By Device Type

• Non-Smart/Traditional Type
• Smart Type

By Connectivity

• Non-Connected
• Connected

By End Use

• Hospitals
• Ambulatory Surgery Centers & Clinics
• Homecare